BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sherid M, Sifuentes H, Samo S, Deepak P, Sridhar S. Lubiprostone induced ischemic colitis. World J Gastroenterol 2013; 19(2): 299-303 [PMID: 23345954 DOI: 10.3748/wjg.v19.i2.299]
URL: https://www.wjgnet.com/1948-5190/full/v19/i2/299.htm
Number Citing Articles
Lubiprostone for chronic constipation in adults: Table:Drug and Therapeutics Bulletin 2014; 52(4): 42 doi: 10.1136/dtb.2014.4.0246
Muhammed Sherid, Humberto Sifuentes, Salih Samo, Samian Sulaiman, Husein Husein, Ruth Tupper, Charles Spurr, John Vainder, Subbaramiah Sridhar. Risk Factors of Recurrent Ischemic Colitis: A Multicenter Retrospective StudyThe Korean Journal of Gastroenterology 2014; 63(5): 283 doi: 10.4166/kjg.2014.63.5.283
Lawrence J Brandt, Paul Feuerstadt, George F Longstreth, Scott J Boley. ACG Clinical Guideline: Epidemiology, Risk Factors, Patterns of Presentation, Diagnosis, and Management of Colon Ischemia (CI)American Journal of Gastroenterology 2015; 110(1): 18 doi: 10.1038/ajg.2014.395
Muhammed Sherid, Humberto Sifuentes, Salih Samo, Samian Sulaiman, Husein Husein, Ruth Tupper, Sankara N Sethuraman, Charles Spurr, John A Vainder, Subbaramiah Sridhar. Ischemic colitis: A forgotten entity. Results of a retrospective study in 118 patientsJournal of Digestive Diseases 2014; 15(11): 606 doi: 10.1111/1751-2980.12182
Nicholas Wilson, Ron Schey. Lubiprostone in constipation: clinical evidence and place in therapyTherapeutic Advances in Chronic Disease 2015; 6(2): 40 doi: 10.1177/2040622314567678
Corrado Blandizzi, Carmelo Scarpignato. A worldwide yearly survey of new data in adverse drug reactionsSide Effects of Drugs Annual 2014; 36: 539 doi: 10.1016/B978-0-444-63407-8.00036-8
Hong Yang, Tonghui Ma. Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and PatentsFrontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00418
Chris Shamatutu, Daljeet Chahal, Isabella T. Tai, Peter Kwan, Hirotada Akiho. Ischemic Colitis after Colonoscopy with Bisacodyl Bowel Preparation: A Report of Two CasesCase Reports in Gastrointestinal Medicine 2020; 2020: 1 doi: 10.1155/2020/8886817
LubiprostoneReactions Weekly 2013; 1444(1): 26 doi: 10.1007/s40278-013-2101-6
Muhammed Sherid, Salih Samo, Samian Sulaiman, Husein Husein, Sankara N. Sethuraman, John A. Vainder. Is CT Angiogram of the Abdominal Vessels Needed following the Diagnosis of Ischemic Colitis? A Multicenter Community StudyISRN Gastroenterology 2014; 2014: 1 doi: 10.1155/2014/756926
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi. The safety of novel drugs used to treat irritable bowel syndromeExpert Opinion on Drug Safety 2014; 13(5): 625 doi: 10.1517/14740338.2014.902932
Christopher Anton, Colin Crawford. Adverse effects of laxatives: updateAdverse Drug Reaction Bulletin 2017; 303(1): 1171 doi: 10.1097/FAD.0000000000000023
Supriya Rao, H. Christian Weber. New treatment targets for the management of irritable bowel syndromeCurrent Opinion in Endocrinology, Diabetes & Obesity 2014; 21(1): 9 doi: 10.1097/MED.0000000000000034
Emanuel Raschi, Fabrizio De Ponti. Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndromeExpert Opinion on Drug Metabolism & Toxicology 2014; 10(2): 293 doi: 10.1517/17425255.2013.876410
Fan Li, Tao Fu, Wei-Dong Tong, Bao-Hua Liu, Chun-Xue Li, Yu Gao, Jin-Song Wu, Xiang-Feng Wang, An-Ping Zhang. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel SyndromeMayo Clinic Proceedings 2016; 91(4): 456 doi: 10.1016/j.mayocp.2016.01.015